V. Deerlin

发表

Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

D. G. Clark, Charles D. Smith, Jason J. Corneveaux, 2011, Nature Genetics.

Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease

D. G. Clark, Charles D. Smith, Jason J. Corneveaux, 2011 .

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Matthew H. Bailey, J. Haines, M. Pericak-Vance, 2013, Neuron.

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

Murray Grossman, Leslie M. Shaw, John Q. Trojanowski, 2014, Alzheimer's & Dementia.

Title Common variant rs 356182 near SNCA defines a Parkinson ' s disease endophenotype

T. Montine, J. Trojanowski, J. Quinn, 2016 .

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative

D. Geschwind, G. Schellenberg, B. Miller, 2007, The Lancet Neurology.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

Kevin F. Bieniek, B. Miller, C. Geula, 2019, Acta Neuropathologica.

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

Timothy A. Miller, Jennifer E. Phillips-Cremins, Lilah M. Besser, 2020, Neuron.

The Penn ADCC: Integrating Neurodegenerative Disease Research Across Disciplines, Conditions, and Population Groups

J. Trojanowski, J. Karlawish, S. Arnold, 2015 .

Conventional and Real-Time Polymerase Chain Reaction

A. Bossler, V. Deerlin, 2009 .

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

N. Fox, C. Cotman, J. Grafman, 2014, Acta Neuropathologica.

FUS pathology deﬁnes the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

P. Deyn, J. Trojanowski, M. Rossor, 2010 .

Edinburgh Research Explorer Genetic risk of Parkinson disease and progression:

D. Hernandez, M. Nalls, A. Singleton, 2022 .

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

Kevin F. Bieniek, C. Geula, M. Mesulam, 2018, The Lancet Neurology.

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Timothy A. Miller, Sonja W. Scholz, Jennifer E. Phillips-Cremins, 2020, Neuron.

Advancing Alzheimer's Diagnosis, Treatment and Care: Recommendations from the Ware Invitational Summit

R. Brookmeyer, J. Trojanowski, K. Blennow, 2013 .

Design of comprehensive Alzheimer's disease centers to address unmet national needs

Christos Davatzikos, Murray Grossman, Mary Naylor, 2010, Alzheimer's & Dementia.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic

Timothy A. Miller, Denis C. Bauer, Shankaracharya, 2018 .

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

Sonja W. Scholz, John D. Eicher, D. Hernandez, 2018, The Lancet Neurology.

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

A. Myers, J. Trojanowski, J. Karlawish, 2007, Neurobiology of Disease.

Ftld-tdp to Tau Ratio Is a Biomarker for 181 Reduced Csf P-tau

Chadwick M. Hales, William T. Hu, J. Trojanowski, 2022 .

LRP10 in α-synucleinopathies

D. Hernandez, J. Morris, J. Trojanowski, 2018, The Lancet Neurology.

TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling

B. Garcia, J. Trojanowski, S. Berger, 2017, Current Biology.

Frontotemporal dementia and its subtypes: a genome-wide association study

Alexander Gerhard, Adrian Danek, Luigi Ferrucci, 2014, The Lancet Neurology.

Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study

Sonja W. Scholz, D. Hernandez, A. Singleton, 2018 .

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

D. Rujescu, H. Hakonarson, U. Lindenberger, 2015, Alzheimer's & Dementia.

Genetic Testing and Parkinson Disease: Assessment of Patient Knowledge, Attitudes, and Interest

A. Siderowf, S. Xie, V. Deerlin, 2011, Journal of Genetic Counseling.

Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit

R. Brookmeyer, D. Meier, M. Naylor, 2012, Alzheimer's & Dementia.

Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer’s disease

G. Schellenberg, T. Bird, J. Leverenz, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Intermediate Repeats Confer Risk for Corticobasal Degeneration and Increase C 9 orf 72 Expression

G. Schellenberg, J. Trojanowski, D. Dickson, 2020 .

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Margaret Sutherland, John P A Ioannidis, Daniel Weintraub, 2015, The Lancet Neurology.

Building an integrated neurodegenerative disease database at an academic health center

Murray Grossman, John Q. Trojanowski, Steven E. Arnold, 2011, Alzheimer's & Dementia.

OP-BRAI180237 2895..2907

D. Hernandez, M. Nalls, A. Singleton, 2018 .

Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease

T. Montine, J. Trojanowski, J. Quinn, 2017, Neurobiology of Aging.

Interpret With Caution

Julene K. Johnson, O. Suchowersky, V. Deerlin, 2016 .

CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease

J. Trojanowski, C. Clark, A. Siderowf, 2010, Neurology.

Progression of alpha‐synuclein pathology in multiple system atrophy of the cerebellar type

John L. Robinson, J. Trojanowski, M. Grossman, 2017, Neuropathology and applied neurobiology.

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations

J. Trojanowski, M. Grossman, C. Clark, 2008, Neurology.

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease

James E. Tomkins, B. Alipanahi, J. Trojanowski, 2020, medRxiv.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

C. Geula, M. Mesulam, J. Grafman, 2019, Acta Neuropathologica.

Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies

D. Hernandez, D. Stone, R. Petersen, 2017, Neurobiology of Aging.

Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration

A Chatterjee, J Q Trojanowski, X Wang, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Common genetic variation is associated with longitudinal decline and network features in behavioral variant frontotemporal degeneration

D. Irwin, S. Xie, C. Olm, 2021, Neurobiology of Aging.

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

C. Cotman, J. Grafman, J. Trojanowski, 2014, Acta Neuropathologica.